ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.975
-0.075 (-2.46%)
Apr 3, 2025, 2:55 PM EDT - Market open
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $2.54 billion as of April 3, 2025. Its market cap has decreased by -27.29% in one year.
Market Cap
2.54B
Enterprise Value
3.16B
1-Year Change
-27.29%
Ranking
Category
Stock Price
$2.98
Market Cap Chart
Since July 28, 2015, ImmunityBio's market cap has decreased from $2.67B to $2.54B, a decrease of -4.76%. That is a compound annual growth rate of -0.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2025 | 2.60B | 45.92% |
| Dec 31, 2024 | 1.78B | -46.78% |
| Dec 29, 2023 | 3.35B | 65.16% |
| Dec 30, 2022 | 2.03B | -16.05% |
| Dec 31, 2021 | 2.42B | 67.01% |
| Dec 31, 2020 | 1.45B | 288.28% |
| Dec 31, 2019 | 372.80M | 305.66% |
| Dec 31, 2018 | 91.90M | -74.24% |
| Dec 29, 2017 | 356.80M | -24.28% |
| Dec 30, 2016 | 471.20M | -66.52% |
| Dec 31, 2015 | 1.41B | -47.21% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.75B |
| UnitedHealth Group | 478.58B |
| Johnson & Johnson | 374.39B |
| AbbVie | 362.98B |
| Novo Nordisk | 301.38B |
| Abbott Laboratories | 228.81B |
| AstraZeneca | 225.76B |
| Merck & Co. | 218.75B |